1
|
Gouzerh F, Vigo G, Dormont L, Buatois B, Hervé MR, Mancini M, Maraver A, Thomas F, Ganem G. Urinary VOCs as biomarkers of early stage lung tumour development in mice. Cancer Biomark 2024; 39:113-125. [PMID: 37980646 PMCID: PMC11002722 DOI: 10.3233/cbm-230070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 10/05/2023] [Indexed: 11/21/2023]
Abstract
BACKGROUND Lung cancer is the primary cause of cancer-induced death. In addition to prevention and improved treatment, it has increasingly been established that early detection is critical to successful remission. OBJECTIVE The aim of this study was to identify volatile organic compounds (VOCs) in urine that could help diagnose mouse lung cancer at an early stage of its development. METHODS We analysed the VOC composition of urine in a genetically engineered lung adenocarcinoma mouse model with oncogenic EGFR doxycycline-inducible lung-specific expression. We compared the urinary VOCs of 10 cancerous mice and 10 healthy mice (controls) before and after doxycycline induction, every two weeks for 12 weeks, until full-blown carcinomas appeared. We used SPME fibres and gas chromatography - mass spectrometry to detect variations in cancer-related urinary VOCs over time. RESULTS This study allowed us to identify eight diagnostic biomarkers that help discriminate early stages of cancer tumour development (i.e., before MRI imaging techniques could identify it). CONCLUSION The analysis of mice urinary VOCs have shown that cancer can induce changes in odour profiles at an early stage of cancer development, opening a promising avenue for early diagnosis of lung cancer in other models.
Collapse
Affiliation(s)
- Flora Gouzerh
- CREEC/MIVEGEC, Centre de Recherches Ecologiques et Evolutives sur le Cancer/Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France
- CEFE, Université Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, Montpellier, France
| | - Gwenaëlle Vigo
- CREEC/MIVEGEC, Centre de Recherches Ecologiques et Evolutives sur le Cancer/Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France
| | - Laurent Dormont
- CEFE, Université Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, Montpellier, France
| | - Bruno Buatois
- CEFE, Université Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, Montpellier, France
| | - Maxime R. Hervé
- IGEPP, Institut de Génétique, Environnement et Protection des Plantes, INRAE, Institut Agro, Université de Rennes, Rennes, France
| | - Maicol Mancini
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Inserm U1194-ICM-Université Montpellier, Montpellier, France
| | - Antonio Maraver
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Inserm U1194-ICM-Université Montpellier, Montpellier, France
| | - Frédéric Thomas
- CREEC/MIVEGEC, Centre de Recherches Ecologiques et Evolutives sur le Cancer/Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France
| | - Guila Ganem
- ISEM, Institut des Sciences de l’Evolution, UMR 5554, Université Montpellier, CNRS, IRD, Montpellier, France
| |
Collapse
|
2
|
Holbrook KL, Badmos S, Habib A, Landa EN, Quaye GE, Pokojovy M, Su X, Lee WY. Investigating the effects of storage conditions on urinary volatilomes for their reliability in disease diagnosis. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY 2023; 11:481-499. [PMID: 38148934 PMCID: PMC10749378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 08/31/2023] [Indexed: 12/28/2023]
Abstract
BACKGROUND Cancer detection presents challenges regarding invasiveness, cost, and reliability. As a result, exploring alternative diagnostic methods holds significant clinical importance. Urinary metabolomic profiling has emerged as a promising avenue; however, its application for cancer diagnosis may be influenced by sample preparation or storage conditions. OBJECTIVE This study aimed to assess the impact of sample storage and processing conditions on urinary volatile organic compounds (VOCs) profiles and establish a robust standard operating procedure (SOP) for such diagnostic applications. METHODS Five key variables were investigated: storage temperatures, durations, freeze-thaw cycles, sample collection conditions, and sample amounts. The analysis of VOCs involved stir bar sorptive extraction coupled with thermal desorption-gas chromatography/mass spectrometry (SBSE-TD-GC-MS), with compound identification facilitated by the National Institute of Standards and Technology Library (NIST). Extensive statistical analysis, including combined scatterplot and response surface (CSRS) plots, partial least squares-discriminant analysis (PLS-DA), and probability density function plots (PDFs), were employed to study the effects of the factors. RESULTS Our findings revealed that urine storage duration, sample amount, temperature, and fasting/non-fasting sample collection did not significantly impact urinary metabolite profiles. This suggests flexibility in urine sample collection conditions, enabling individuals to contribute samples under varying circumstances. However, the influence of freeze-thaw cycles was evident, as VOC profiles exhibited distinct clustering patterns based on the number of cycles. This emphasizes the effect of freeze-thaw cycles on the integrity of urinary profiles. CONCLUSIONS The developed SOP integrating SBSE-TD-GC-MS and statistical analyses can serve as a valuable tool for analyzing urinary organic compounds with minimal preparation and sensitive detection. The findings also support that urinary VOCs for cancer screening and diagnosis could be a feasible alternative offering a robust, non-invasive, and sensitive approach for cancer screening.
Collapse
Affiliation(s)
- Kiana L Holbrook
- Department of Chemistry and Biochemistry, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Sabur Badmos
- Department of Chemistry and Biochemistry, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Ahsan Habib
- Department of Chemistry and Biochemistry, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Elizabeth Noriega Landa
- Department of Chemistry and Biochemistry, University of Texas at El PasoEl Paso, TX 79968, USA
| | - George E Quaye
- Department of Mathematical Sciences, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Michael Pokojovy
- Department of Mathematical Sciences, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Xiaogang Su
- Department of Mathematical Sciences, University of Texas at El PasoEl Paso, TX 79968, USA
| | - Wen-Yee Lee
- Department of Chemistry and Biochemistry, University of Texas at El PasoEl Paso, TX 79968, USA
| |
Collapse
|
3
|
Wiesel O, Sung SW, Katz A, Leibowitz R, Bar J, Kamer I, Berger I, Nir-Ziv I, Mark Danieli M. A Novel Urine Test Biosensor Platform for Early Lung Cancer Detection. BIOSENSORS 2023; 13:627. [PMID: 37366992 DOI: 10.3390/bios13060627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 05/27/2023] [Accepted: 05/31/2023] [Indexed: 06/28/2023]
Abstract
Lung cancer is the leading cause of cancer-related mortality worldwide. Early detection is essential to achieving a better outcome and prognosis. Volatile organic compounds (VOCs) reflect alterations in the pathophysiology and body metabolism processes, as shown in various types of cancers. The biosensor platform (BSP) urine test uses animals' unique, proficient, and accurate ability to scent lung cancer VOCs. The BSP is a testing platform for the binary (negative/positive) recognition of the signature VOCs of lung cancer by trained and qualified Long-Evans rats as biosensors (BSs). The results of the current double-blind study show high accuracy in lung cancer VOC recognition, with 93% sensitivity and 91% specificity. The BSP test is safe, rapid, objective and can be performed repetitively, enabling periodic cancer monitoring as well as an aid to existing diagnostic methods. The future implementation of such urine tests as routine screening and monitoring tools has the potential to significantly increase detection rate as well as curability rates with lower healthcare expenditure. This paper offers a first instructive clinical platform utilizing VOC's in urine for detection of lung cancer using the innovative BSP to deal with the pressing need for an early lung cancer detection test tool.
Collapse
Affiliation(s)
- Ory Wiesel
- Division of Thoracic and Esophageal Surgery the Cardiovascular Center, Tzafon Medical Center, Affiliated to Azrieli Faculty of Medicine, Bar-Ilan University, Poriya 1520800, Israel
| | - Sook-Whan Sung
- Department of Thoracic and Cardiovascular Surgery, Ewha Womens University Seoul Hospital, 260 Gonghang-daero, Gangseo-gu, Seoul 07804, Republic of Korea
| | - Amit Katz
- Head of Thoracic Surgery, Rambam Health Care Campus, P.O. Box 9602, Haifa 3109601, Israel
| | - Raya Leibowitz
- Oncology institute, Shamir Medical Center, Zerifin 703001, Israel
| | - Jair Bar
- Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel
| | - Iris Kamer
- Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel
| | - Itay Berger
- Early OM, 4 Meir Ariel St., Natanya 4253063, Israel
| | | | | |
Collapse
|
4
|
Piqueret B, Montaudon É, Devienne P, Leroy C, Marangoni E, Sandoz JC, d'Ettorre P. Ants act as olfactory bio-detectors of tumours in patient-derived xenograft mice. Proc Biol Sci 2023; 290:20221962. [PMID: 36695032 PMCID: PMC9874262 DOI: 10.1098/rspb.2022.1962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Accepted: 12/22/2022] [Indexed: 01/26/2023] Open
Abstract
Early detection of cancer is critical in medical sciences, as the sooner a cancer is diagnosed, the higher are the chances of recovery. Tumour cells are characterized by specific volatile organic compounds (VOCs) that can be used as cancer biomarkers. Through olfactory associative learning, animals can be trained to detect these VOCs. Insects such as ants have a refined sense of smell, and can be easily and rapidly trained with olfactory conditioning. Using urine from patient-derived xenograft mice as stimulus, we demonstrate that individual ants can learn to discriminate the odour of healthy mice from that of tumour-bearing mice and do so after only three conditioning trials. After training, they spend approximately 20% more time in the vicinity of the learned odour than beside the other stimulus. Chemical analyses confirmed that the presence of the tumour changed the urine odour, supporting the behavioural results. Our study demonstrates that ants reliably detect tumour cues in mice urine and have the potential to act as efficient and inexpensive cancer bio-detectors.
Collapse
Affiliation(s)
- Baptiste Piqueret
- Laboratory of Experimental and Comparative Ethology, Université Sorbonne Paris Nord, Villetaneuse UR4443, France
| | - Élodie Montaudon
- Translational Research Department, Institut Curie, 26 Rue d'Ulm, 75005 Paris, France
| | - Paul Devienne
- Laboratory of Experimental and Comparative Ethology, Université Sorbonne Paris Nord, Villetaneuse UR4443, France
| | - Chloé Leroy
- Laboratory of Experimental and Comparative Ethology, Université Sorbonne Paris Nord, Villetaneuse UR4443, France
| | - Elisabetta Marangoni
- Translational Research Department, Institut Curie, 26 Rue d'Ulm, 75005 Paris, France
| | - Jean-Christophe Sandoz
- Evolution, Genomes, Behaviour and Ecology, Université Paris-Saclay, CNRS, IRD, 91190 Gif-sur-Yvette, France
| | - Patrizia d'Ettorre
- Laboratory of Experimental and Comparative Ethology, Université Sorbonne Paris Nord, Villetaneuse UR4443, France
- Institut Universitaire de France (IUF), Paris, France
| |
Collapse
|
5
|
Piqueret B, Sandoz JC, d’Ettorre P. The neglected potential of invertebrates in detecting disease via olfaction. Front Ecol Evol 2023. [DOI: 10.3389/fevo.2022.960757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Agents that cause disease alter the cell metabolism of their hosts. Cells with an altered metabolism produce particular profiles of biomolecules, which are different from those of healthy cells. Such differences may be detected by olfaction. Historically, physicians used olfactory cues to diagnose sickness by smelling the breath or the urine of patients. However, other species have been shown to possess excellent olfactory abilities. Dogs, for instance, have been frequently used as biodetectors of human diseases, including cancer, viral and bacterial infections. Other mammalian species, such as rats, have been trained to perform similar tasks, but their disease detection abilities remain poorly explored. Here, we focus on the overlooked potential of invertebrate species and we review the current literature on olfactory detection of diseases by these animals. We discuss the possible advantages of exploring further the abilities of invertebrates as detection tools for human disease.
Collapse
|
6
|
Oxner M, Trang A, Mehta J, Forsyth C, Swanson B, Keshavarzian A, Bhushan A. The Versatility and Diagnostic Potential of VOC Profiling for Noninfectious Diseases. BME FRONTIERS 2023; 4:0002. [PMID: 37849665 PMCID: PMC10521665 DOI: 10.34133/bmef.0002] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Accepted: 11/11/2022] [Indexed: 10/19/2023] Open
Abstract
A variety of volatile organic compounds (VOCs) are produced and emitted by the human body every day. The identity and concentration of these VOCs reflect an individual's metabolic condition. Information regarding the production and origin of VOCs, however, has yet to be congruent among the scientific community. This review article focuses on the recent investigations of the source and detection of biological VOCs as a potential for noninvasive discrimination between healthy and diseased individuals. Analyzing the changes in the components of VOC profiles could provide information regarding the molecular mechanisms behind disease as well as presenting new approaches for personalized screening and diagnosis. VOC research has prioritized the study of cancer, resulting in many research articles and reviews being written on the topic. This review summarizes the information gained about VOC cancer studies over the past 10 years and looks at how this knowledge correlates with and can be expanded to new and upcoming fields of VOC research, including neurodegenerative and other noninfectious diseases. Recent advances in analytical techniques have allowed for the analysis of VOCs measured in breath, urine, blood, feces, and skin. New diagnostic approaches founded on sensor-based techniques allow for cheaper and quicker results, and we compare their diagnostic dependability with gas chromatography- and mass spectrometry-based techniques. The future of VOC analysis as a clinical practice and the challenges associated with this transition are also discussed and future research priorities are summarized.
Collapse
Affiliation(s)
- Micah Oxner
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA
| | - Allyson Trang
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA
| | - Jhalak Mehta
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA
| | - Christopher Forsyth
- Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Section of Gastroenterology, Rush Medical College, Chicago, IL 60612, USA
| | - Barbara Swanson
- Department of Adult Health and Gerontological Nursing, Rush University College of Nursing, Chicago, IL 60612, USA
| | - Ali Keshavarzian
- Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Section of Gastroenterology, Rush Medical College, Chicago, IL 60612, USA
| | - Abhinav Bhushan
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA
| |
Collapse
|
7
|
Gouzerh F, Ganem G, Pichevin A, Dormont L, Thomas F. Ability of animals to detect cancer odors. Biochim Biophys Acta Rev Cancer 2023; 1878:188850. [PMID: 36528192 DOI: 10.1016/j.bbcan.2022.188850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Revised: 12/12/2022] [Accepted: 12/12/2022] [Indexed: 12/23/2022]
Abstract
The olfactory capacity of animals has long been used by humans to help with various activities, e.g., hunting, detecting mines, locating people, and diagnosing diseases. Cancer is among the leading diseases causing death worldwide. Several recent studies have underscored the benefit of using scent to detect cancer, and this paper will review the studies using animals to detect tumor scents. A large variety of animals have been used for this purpose-dogs, rodents, insects, and nematodes-and have shown their capacity to detect cancer, with a success rate close to 90%. Here we discuss these studies, their methodologies, and the animal models used. Finally, we discuss the medical perspectives for cancer diagnosis using odors.
Collapse
Affiliation(s)
- Flora Gouzerh
- Centre de Recherches Écologiques et Évolutives sur le Cancer, Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, UMR IRD 224- CNRS 5290- Université de Montpellier, 34394 Montpellier, France; Centre d'Ecologie Fonctionnelle et Evolutive, Université́ de Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, 34293 Montpellier, France.
| | - Guila Ganem
- Institut des Sciences de l'Evolution, ISEM, Université Montpellier, CNRS, IRD, 34095 Montpellier, France
| | - Anaïs Pichevin
- Centre d'Ecologie Fonctionnelle et Evolutive, Université́ de Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, 34293 Montpellier, France
| | - Laurent Dormont
- Centre d'Ecologie Fonctionnelle et Evolutive, Université́ de Montpellier, CNRS, EPHE, IRD, Université Paul Valéry Montpellier 3, 34293 Montpellier, France
| | - Frédéric Thomas
- Centre de Recherches Écologiques et Évolutives sur le Cancer, Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, UMR IRD 224- CNRS 5290- Université de Montpellier, 34394 Montpellier, France
| |
Collapse
|
8
|
Teränen V, Nissinen S, Roine A, Antila A, Siiki A, Vaalavuo Y, Kumpulainen P, Oksala N, Laukkarinen J. Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study. Front Oncol 2022; 12:918539. [PMID: 36479080 PMCID: PMC9720309 DOI: 10.3389/fonc.2022.918539] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Accepted: 10/31/2022] [Indexed: 08/30/2023] Open
Abstract
OBJECTIVES Detection of volatile organic compounds (VOCs) from bodily fluids with field asymmetric waveform ion mobility spectrometry (FAIMS) and related methods has been studied in various settings. Preliminary results suggest that it is possible to detect prostate, colorectal, ovarian and pancreatic cancer from urine samples. In this study, our primary aim was to differentiate pancreatic cancer from pancreatitis and benign tumours of the pancreas by using bile samples obtained during endoscopic retrograde cholangiopancreatography (ERCP). Secondarily, we aimed to differentiate all pancreatic region malignancies from all other kinds of benign causes of biliary obstruction. METHODS A bile sample was successfully aspirated from 94 patients during ERCP in Tampere University Hospital. Hospital and patient records were prospectively followed up for at least two years after ERCP. Bile samples were analysed using a Lonestar chemical analyser (Owlstone, UK) using an ATLAS sampling system and a split-flow box. Diagnoses and corresponding data from the analyses were matched and divided into two subcategories for comparison. Statistical analysis was performed using linear discriminant analysis, support vector machines, and 5-fold cross-validation. RESULTS Pancreatic cancers (n=8) were differentiated from benign pancreatic lesions (n=9) with a sensitivity of 100%, specificity of 77.8%, and correct rate of 88%. All pancreatic region cancers (n=19) were differentiated from all other kinds of benign causes of biliary obstruction (n=75) with corresponding values of 21.1%, 94.7%, and 80.7%. The sample size was too small to try to differentiate pancreatic cancers from adjacent cancers. CONCLUSION Analysing bile VOCs using FAIMS shows promising capability in detecting pancreatic cancer and other cancers in the pancreatic area.
Collapse
Affiliation(s)
- Ville Teränen
- Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Samuli Nissinen
- Department of Internal Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
| | - Antti Roine
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Anne Antila
- Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
| | - Antti Siiki
- Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
| | - Yrjö Vaalavuo
- Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
| | - Pekka Kumpulainen
- Department of Internal Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
| | - Niku Oksala
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Johanna Laukkarinen
- Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| |
Collapse
|
9
|
Namgong C, Kim JH, Lee MH, Midkiff D. Non-invasive cancer detection in canine urine through Caenorhabditis elegans chemotaxis. Front Vet Sci 2022; 9:932474. [PMID: 36016810 PMCID: PMC9396970 DOI: 10.3389/fvets.2022.932474] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Accepted: 07/12/2022] [Indexed: 11/16/2022] Open
Abstract
Cancer is the leading cause of death in companion animals, and successful early treatment has been a challenge in the veterinary field. We have developed the Non-Invasive Cancer Screening (N.C.S.) Study to perform cancer detection through the analysis of canine urine samples. The test makes use of the strong olfactory system of the nematode Caenorhabditis elegans, which was previously shown to positively respond to urine samples from human cancer patients. We performed a proof-of-concept study to optimize the detection capability in urine samples obtained from dogs with naturally occurring cancers. In this study, we established a scale for identifying the cancer risk based on the magnitude of the chemotaxis index of C. elegans toward a canine urine sample. Through validation, the N.C.S. Study achieved a sensitivity of 85%, showing that it is highly sensitive to indicate the presence of cancer across multiple types of common canine cancers. The test also showed a 90% specificity to cancer samples, indicating a low rate of over-identifying cancer risk. From these results, we have demonstrated the ability to perform low-cost, non-invasive cancer detection in companion animals—a method that can increase the ability to perform cancer diagnosis and treatment.
Collapse
Affiliation(s)
- Chan Namgong
- Animal Cancer Dx, Raleigh, NC, United States
- *Correspondence: Chan Namgong
| | - Jong Hyuk Kim
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, United States
- IntelligentComparative Oncology Lab, College of Veterinary Medicine, University of Florida, Gainesville, FL, United States
| | - Myon Hee Lee
- Division of Hematology/Oncology, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, United States
| | - Daniel Midkiff
- Animal Cancer Dx, Raleigh, NC, United States
- Daniel Midkiff
| |
Collapse
|
10
|
Kochevalina MY, Bukharina AB, Trunov VG, Pento AV, Morozova OV, Kogun' GA, Simanovsky YO, Nikiforov SM, Rodionova EI. Changes in the urine volatile metabolome throughout growth of transplanted hepatocarcinoma. Sci Rep 2022; 12:7774. [PMID: 35546342 PMCID: PMC9095867 DOI: 10.1038/s41598-022-11818-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 04/27/2022] [Indexed: 11/26/2022] Open
Abstract
Trained detection dogs distinguish between urine samples from healthy organisms and organisms with malignant tumors, suggesting that the volatile urine metabolome contains information about tumor progression. The aim of this study was to determine whether the stage of tumor growth affects the chemical differences in the urine of mice and to what extent the "olfactory image of disease" perceived by dogs coincides with the "image of disease" recorded by the mass spectrometer. We used a novel laser ionization mass spectrometry method and propose a mass spectrometric analysis without detailed interpretation of the spectrum of volatile metabolomes in urine. The mass spectrometer we use works without sample preparation and registers volatile organic compounds in air at room temperature without changing the pH of the sample, i.e. under conditions similar to those in which dogs solve the same problem. The experimental cancer models were male BDF-f1 hybrid mice transplanted with hepatocarcinoma tissue, and similar mice transplanted with healthy liver tissue were used as controls. Our data show that both dogs and our proposed laser mass spectrometry method are able to detect both the entire spectrum of volatile organic compounds associated with the disease and minor changes in this spectrum during its course.
Collapse
Affiliation(s)
- M Yu Kochevalina
- Kharkevich Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow, Russia
| | - A B Bukharina
- Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Russia
| | - V G Trunov
- Kharkevich Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow, Russia
| | - A V Pento
- Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Russia
| | - O V Morozova
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - G A Kogun'
- Cynological Division of Aviation Security Service, Aeroflot, Russian Airlines, Moscow, Russia
| | - Ya O Simanovsky
- Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Russia
| | - S M Nikiforov
- Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Russia
| | - E I Rodionova
- Kharkevich Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow, Russia.
| |
Collapse
|
11
|
Sato T, Matsukawa M, Iijima T, Mizutani Y. Hierarchical Elemental Odor Coding for Fine Discrimination Between Enantiomer Odors or Cancer-Characteristic Odors. Front Behav Neurosci 2022; 16:849864. [PMID: 35530728 PMCID: PMC9074825 DOI: 10.3389/fnbeh.2022.849864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 03/14/2022] [Indexed: 11/13/2022] Open
Abstract
Odors trigger various emotional responses such as fear of predator odors, aversion to disease or cancer odors, attraction to male/female odors, and appetitive behavior to delicious food odors. Odor information processing for fine odor discrimination, however, has remained difficult to address. The olfaction and color vision share common features that G protein-coupled receptors are the remote sensors. As different orange colors can be discriminated by distinct intensity ratios of elemental colors, such as yellow and red, odors are likely perceived as multiple elemental odors hierarchically that the intensities of elemental odors are in order of dominance. For example, in a mixture of rose and fox-unique predator odors, robust rose odor alleviates the fear of mice to predator odors. Moreover, although occult blood odor is stronger than bladder cancer-characteristic odor in urine samples, sniffer mice can discriminate bladder cancer odor in occult blood-positive urine samples. In forced-choice odor discrimination tasks for pairs of enantiomers or pairs of body odors vs. cancer-induced body odor disorders, sniffer mice discriminated against learned olfactory cues in a wide range of concentrations, where correct choice rates decreased in the Fechner's law, as perceptual ambiguity increased. In this mini-review, we summarize the current knowledge of how the olfactory system encodes and hierarchically decodes multiple elemental odors to control odor-driven behaviors.
Collapse
Affiliation(s)
- Takaaki Sato
- Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Osaka, Japan
| | - Mutsumi Matsukawa
- Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Tokyo, Japan
| | - Toshio Iijima
- Graduate School of Life Sciences, Tohoku University, Sendai, Japan
| | - Yoichi Mizutani
- Department of Medical Engineering, Faculty of Health Science, Aino University, Osaka, Japan
| |
Collapse
|
12
|
Gouzerh F, Buatois B, Hervé MR, Mancini M, Maraver A, Dormont L, Thomas F, Ganem G. Odours of cancerous mouse congeners: detection and attractiveness. Biol Open 2022; 11:275010. [PMID: 35403195 PMCID: PMC9065363 DOI: 10.1242/bio.059208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 03/31/2022] [Indexed: 11/30/2022] Open
Abstract
Chemical communication plays a major role in social interactions. Cancer, by inducing changes in body odours, may alter interactions between individuals. In the framework of research targeting non-invasive methods to detect early stages of cancer development, this study asked whether untrained mice could detect odour changes in cancerous congeners. If yes, were they able to detect cancer at an early developmental stage? Did it influence female preference? Did variations in volatile organic components of the odour source paralleled mice behavioural responses? We used transgenic mice strains developing or not lung cancer upon antibiotic ingestion. We sampled soiled bedding of cancerous mice (CC) and not cancerous mice (NC), at three experimental conditions: before (T0), early stage (T2) and late stage (T12) of cancer development. Habituation/generalisation and two-way preference tests were performed where soiled beddings of CC and NC mice were presented to wild-derived mice. The composition and relative concentration of volatile organic components (VOC) in the two stimuli types were analysed. Females did not show directional preference at any of the experimental conditions, suggesting that cancer did not influence their choice behaviour. Males did not discriminate between CC and NC stimuli at T0 but did so at T2 and T12, indicating that wild-derived mice could detect cancer at an early stage of development. Finally, although the VOC bouquet differed between CC and NC it did not seem to parallel the observed behavioural response suggesting that other types of odorant components might be involved in behavioural discrimination between CC and NC mice. Summary: Male mice could discriminate the smell of cancerous congeners even when the tumour was hardly detectable by other means; however, females did not discriminate against the smell of males carrying cancerous tumours. Odorant molecules other than volatile organic compounds analysed here might explain the observed behaviour.
Collapse
Affiliation(s)
- Flora Gouzerh
- CREEC/ MIVEGEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.,CEFE, Univ Montpellier, CNRS, EPHE, IRD, Univ Paul Valéry Montpellier 3, Montpellier, France
| | - Bruno Buatois
- CEFE, Univ Montpellier, CNRS, EPHE, IRD, Univ Paul Valéry Montpellier 3, Montpellier, France
| | - Maxime R Hervé
- IGEPP, INRAE, Institut Agro, Univ Rennes, 35000, Rennes, France
| | | | | | - Laurent Dormont
- CEFE, Univ Montpellier, CNRS, EPHE, IRD, Univ Paul Valéry Montpellier 3, Montpellier, France
| | - Frédéric Thomas
- CREEC/ MIVEGEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France
| | - Guila Ganem
- Institut des Sciences de l'Evolution, ISEM, Univ Montpellier, CNRS, IRD, Montpellier, France
| |
Collapse
|
13
|
Taunk K, Porto-Figueira P, Pereira JAM, Taware R, da Costa NL, Barbosa R, Rapole S, Câmara JS. Urinary Volatomic Expression Pattern: Paving the Way for Identification of Potential Candidate Biosignatures for Lung Cancer. Metabolites 2022; 12:36. [PMID: 35050157 PMCID: PMC8780352 DOI: 10.3390/metabo12010036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 12/13/2021] [Accepted: 12/21/2021] [Indexed: 12/24/2022] Open
Abstract
The urinary volatomic profiling of Indian cohorts composed of 28 lung cancer (LC) patients and 27 healthy subjects (control group, CTRL) was established using headspace solid phase microextraction technique combined with gas chromatography mass spectrometry methodology as a powerful approach to identify urinary volatile organic metabolites (uVOMs) to discriminate among LC patients from CTRL. Overall, 147 VOMs of several chemistries were identified in the intervention groups-including naphthalene derivatives, phenols, and organosulphurs-augmented in the LC group. In contrast, benzene and terpenic derivatives were found to be more prevalent in the CTRL group. The volatomic data obtained were processed using advanced statistical analysis, namely partial least square discriminative analysis (PLS-DA), support vector machine (SVM), random forest (RF), and multilayer perceptron (MLP) methods. This resulted in the identification of nine uVOMs with a higher potential to discriminate LC patients from CTRL subjects. These were furan, o-cymene, furfural, linalool oxide, viridiflorene, 2-bromo-phenol, tricyclazole, 4-methyl-phenol, and 1-(4-hydroxy-3,5-di-tert-butylphenyl)-2-methyl-3-morpholinopropan-1-one. The metabolic pathway analysis of the data obtained identified several altered biochemical pathways in LC mainly affecting glycolysis/gluconeogenesis, pyruvate metabolism, and fatty acid biosynthesis. Moreover, acetate and octanoic, decanoic, and dodecanoic fatty acids were identified as the key metabolites responsible for such deregulation. Furthermore, studies involving larger cohorts of LC patients would allow us to consolidate the data obtained and challenge the potential of the uVOMs as candidate biomarkers for LC.
Collapse
Affiliation(s)
- Khushman Taunk
- Proteomics Lab, National Centre for Cell Science (NCCS), Ganeshkhind, SPPU Campus, Pune 411007, India; (K.T.); (R.T.)
| | - Priscilla Porto-Figueira
- CQM—Centro de Química da Madeira, Centro de Ciências Exatas e da Engenharia, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (P.P.-F.); (J.A.M.P.)
| | - Jorge A. M. Pereira
- CQM—Centro de Química da Madeira, Centro de Ciências Exatas e da Engenharia, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (P.P.-F.); (J.A.M.P.)
| | - Ravindra Taware
- Proteomics Lab, National Centre for Cell Science (NCCS), Ganeshkhind, SPPU Campus, Pune 411007, India; (K.T.); (R.T.)
| | - Nattane Luíza da Costa
- Instituto de Informática, Alameda Palmeiras, Quadra D, Campus Samambaia, Universidade Federal de Goiás, Goiânia 74690-900, GO, Brazil; (N.L.d.C.); (R.B.)
| | - Rommel Barbosa
- Instituto de Informática, Alameda Palmeiras, Quadra D, Campus Samambaia, Universidade Federal de Goiás, Goiânia 74690-900, GO, Brazil; (N.L.d.C.); (R.B.)
| | - Srikanth Rapole
- Proteomics Lab, National Centre for Cell Science (NCCS), Ganeshkhind, SPPU Campus, Pune 411007, India; (K.T.); (R.T.)
| | - José S. Câmara
- CQM—Centro de Química da Madeira, Centro de Ciências Exatas e da Engenharia, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (P.P.-F.); (J.A.M.P.)
- Faculdade de Ciências Exatas e da Engenharia, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal
| |
Collapse
|
14
|
Osada K, Miyazono S, Ohata M, Noguchi T, Kashiwayanagi M. Changes in gaseous concentration of alkylpyrazine analogs affect mouse avoidance behavior. Biosci Biotechnol Biochem 2021; 85:2343-2351. [PMID: 34647591 DOI: 10.1093/bbb/zbab178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2021] [Accepted: 10/01/2021] [Indexed: 11/14/2022]
Abstract
We developed a rapid and accurate method for quantifying gaseous phase odorants using headspace solid-phase microextraction (HS-SPME) in conjunction with GC-MS and used our system to quantify alkylpyrazine analogs in the Y-maze. Rapid extraction of volatile compounds in the vapor phase achieved accurate quantitative analysis of gaseous alkylpyrazine analogs at several locations in the Y-maze. We also used a series of three SPME fibers to quantify changes in the concentration over time. We conducted a behavioral test of mice in response to these alkylpyrazines and identified a positive relationship between the rate of increase in gaseous concentration and the avoidance rate induced. Our results demonstrate that the Y-maze is a simple but reliable apparatus for behavioral studies of olfaction. The HS-SPME fast extraction method can quantify how gaseous concentrations of alkylpyrazines change over time, and the time-dependent increase of alkylpyrazine concentration is correlated with induction of aversive behavior in mice.
Collapse
Affiliation(s)
- Kazumi Osada
- Laboratory of Food Science and Nutrition, Department of Food Bioscience and Biotechnology, College of Bioresource Sciences, Nihon University, Fujisawa, Japan
- Division of Physiology, Department of Oral Biology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan
| | - Sadaharu Miyazono
- Department of Sensory Physiology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
| | - Motoko Ohata
- Laboratory of Food Science and Nutrition, Department of Food Bioscience and Biotechnology, College of Bioresource Sciences, Nihon University, Fujisawa, Japan
| | - Tomohiro Noguchi
- Department of Sensory Physiology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
| | - Makoto Kashiwayanagi
- Department of Sensory Physiology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
| |
Collapse
|
15
|
Gouzerh F, Bessière JM, Ujvari B, Thomas F, Dujon AM, Dormont L. Odors and cancer: Current status and future directions. Biochim Biophys Acta Rev Cancer 2021; 1877:188644. [PMID: 34737023 DOI: 10.1016/j.bbcan.2021.188644] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Revised: 10/22/2021] [Accepted: 10/23/2021] [Indexed: 02/07/2023]
Abstract
Cancer is the second leading cause of death in the world. Because tumors detected at early stages are easier to treat, the search for biomarkers-especially non-invasive ones-that allow early detection of malignancies remains a central goal to reduce cancer mortality. Cancer, like other pathologies, often alters body odors, and much has been done by scientists over the last few decades to assess the value of volatile organic compounds (VOCs) as signatures of cancers. We present here a quantitative review of 208 studies carried out between 1984 and 2020 that explore VOCs as potential biomarkers of cancers. We analyzed the main findings of these studies, listing and classifying VOCs related to different cancer types while considering both sampling methods and analysis techniques. Considering this synthesis, we discuss several of the challenges and the most promising prospects of this research direction in the war against cancer.
Collapse
Affiliation(s)
- Flora Gouzerh
- CREEC/CANECEV (CREES), Montpellier, France; MIVEGEC, Université de Montpellier, CNRS, IRD, Montpellier, France; CEFE, Univ Montpellier, CNRS, EPHE, IRD, Univ Paul Valéry Montpellier 3, Montpellier, France.
| | - Jean-Marie Bessière
- Ecole Nationale de Chimie de Montpellier, Laboratoire de Chimie Appliquée, Montpellier, France
| | - Beata Ujvari
- Deakin University, School of Life and Environmental Sciences, Centre for Integrative Ecology, Waurn Ponds, Vic 3216, Australia
| | - Frédéric Thomas
- CREEC/CANECEV (CREES), Montpellier, France; MIVEGEC, Université de Montpellier, CNRS, IRD, Montpellier, France
| | - Antoine M Dujon
- CREEC/CANECEV (CREES), Montpellier, France; MIVEGEC, Université de Montpellier, CNRS, IRD, Montpellier, France; Deakin University, School of Life and Environmental Sciences, Centre for Integrative Ecology, Waurn Ponds, Vic 3216, Australia
| | - Laurent Dormont
- CEFE, Univ Montpellier, CNRS, EPHE, IRD, Univ Paul Valéry Montpellier 3, Montpellier, France
| |
Collapse
|
16
|
Wu X, Zhu T, Zhang H, Lu L, He X, Liu C, Fan SJ. Identification of odor biomarkers in irradiation injury urine based on headspace SPME-GC-MS. Int J Radiat Biol 2021; 97:1597-1605. [PMID: 34402727 DOI: 10.1080/09553002.2021.1969050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
PURPOSE The threat of population exposure to ionizing radiation is increasing rapidly worldwide. Such exposure, especially at high-dose, is known to cause acute radiation syndrome (ARS). Hence, it is necessary to develop specific and sensitive biomarkers to accurately diagnose radiation injury and evaluate medical countermeasures. MATERIALS AND METHODS Caenorhabditis elegans (C. elegans), a model organism with a fine and sound olfactory system, was used to examine the odor of urine samples collected from irradiation-injured rats, and compared with those from un-irradiated control rats to investigate the 'special odor' of radiation injury. Subsequently, headspace SPME-GC-MS was applied for non-targeted metabolomic analysis of volatile organic compounds (VOCs) in urine, with the aim to discover changes of small molecule metabolites and identify odor biomarkers of irradiation injury. RESULTS C. elegans showed significant attraction to the urine of total body irradiation (TBI) rats compared with control rats, indicating that irradiation injury can emit 'special odor' and the metabolites in urine VOCs were changed. Using metabolomics based on headspace SPME-GC-MS for metabolic profiles analysis, we screened 63 differentially expressed metabolites. Among them, 10 metabolites including p-Cresol with excellent diagnostic ability were identified as odor biomarkers according to receiver operating characteristic (ROC) curve analysis. CONCLUSIONS This study confirmed the 'special odor' induced by irradiation injury, and identified biomarkers through urine VOCs analysis for the first time, which can provide a novel approach and insight to evaluate irradiation injury noninvasively, accurately and conveniently.[Figure: see text].
Collapse
Affiliation(s)
- Xin Wu
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China
| | - Tong Zhu
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China
| | - Hongbing Zhang
- State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, PR China
| | - Lu Lu
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China
| | - Xin He
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China
| | - Changxiao Liu
- State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, PR China
| | - Sai-Jun Fan
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China
| |
Collapse
|
17
|
Lanza E, Di Rocco M, Schwartz S, Caprini D, Milanetti E, Ferrarese G, Lonardo MT, Pannone L, Ruocco G, Martinelli S, Folli V. C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples. Sci Rep 2021; 11:17133. [PMID: 34429473 PMCID: PMC8385061 DOI: 10.1038/s41598-021-96613-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 08/10/2021] [Indexed: 02/07/2023] Open
Abstract
Chemosensory receptors play a crucial role in distinguishing the wide range of volatile/soluble molecules by binding them with high accuracy. Chemosensation is the main sensory modality in organisms lacking long-range sensory mechanisms like vision/hearing. Despite its low number of sensory neurons, the nematode Caenorhabditis elegans possesses several chemosensory receptors, allowing it to detect about as many odorants as mammals. Here, we show that C. elegans displays attraction towards urine samples of women with breast cancer, avoiding control ones. Behavioral assays on animals lacking AWC sensory neurons demonstrate the relevance of these neurons in sensing cancer odorants: calcium imaging on AWC increases the accuracy of the discrimination (97.22%). Also, chemotaxis assays on animals lacking GPCRs expressed in AWC allow to identify receptors involved in binding cancer metabolites, suggesting that an alteration of a few metabolites is sufficient for the cancer discriminating behavior of C. elegans, which may help identify a fundamental fingerprint of breast cancer.
Collapse
Affiliation(s)
- Enrico Lanza
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| | - Martina Di Rocco
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy ,grid.416651.10000 0000 9120 6856Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, 00161 Italy ,grid.7841.aDepartment of Biochemical Science “A. Rossi Fanelli”, Sapienza Università di Roma, 00185 Rome, Italy
| | - Silvia Schwartz
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| | - Davide Caprini
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| | - Edoardo Milanetti
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy ,grid.7841.aDepartment of Physics, Sapienza Università di Roma, Rome, 00185 Italy
| | - Giuseppe Ferrarese
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| | | | - Luca Pannone
- grid.414125.70000 0001 0727 6809Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, RM 00165 Italy
| | - Giancarlo Ruocco
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| | - Simone Martinelli
- grid.416651.10000 0000 9120 6856Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, 00161 Italy
| | - Viola Folli
- grid.25786.3e0000 0004 1764 2907Istituto Italiano di Tecnologia, Center for Life Nano Science, Rome, 00161 Italy
| |
Collapse
|
18
|
Ma YC, Tian PF, Chen ZP, Yue DS, Liu CC, Li CG, Chen C, Zhang H, Liu HL, Zhang ZF, Chen L, Zhang B, Wang CL. Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer. Cancer Sci 2021; 112:2349-2360. [PMID: 33565687 PMCID: PMC8177790 DOI: 10.1111/cas.14845] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 02/07/2021] [Accepted: 02/08/2021] [Indexed: 12/16/2022] Open
Abstract
Reliable and noninvasive biomarkers for the early diagnosis of non‐small‐cell lung cancer (NSCLC) are an unmet need. This study aimed to screen and validate potential urinary biomarkers for the early diagnosis of NSCLC. Using protein mass spectrometry, urinary MDH2 was found to be abundant both in patients with lung cancer and lung cancer model mice compared with controls. Urine samples obtained as retrospective and prospective cohorts including 1091 NSCLC patients and 736 healthy controls were measured using ELISA. Patients with stage I NSCLC had higher urinary MDH2 compared with healthy controls. The area under the receiver‐operating characteristic curve (AUC) for the urinary MDH2 was 0.7679 and 0.7234 in retrospective and prospective cohorts to distinguish stage I cases from controls. Urinary MDH2 levels correlated with gender and smoking history. MDH2 expression levels were elevated in lung cancer tissues. MDH2 knockdown using shRNA inhibited the proliferation of lung cancer cells. Our study demonstrated that urinary MDH2 concentration was higher in early‐stage NSCLC patients compared with that in controls and that MDH2 could serve as a potential biomarker for early detection of NSCLC.
Collapse
Affiliation(s)
- Yu-Chen Ma
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Peng-Fei Tian
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Zhi-Peng Chen
- Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China
| | - Dong-Sheng Yue
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Cui-Cui Liu
- Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
| | - Chen-Guang Li
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Chen Chen
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Hua Zhang
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Hai-Lin Liu
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Zhen-Fa Zhang
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Liang Chen
- Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China
| | - Bin Zhang
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Chang-Li Wang
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| |
Collapse
|
19
|
Arnal A, Roche B, Gouagna LC, Dujon A, Ujvari B, Corbel V, Remoue F, Poinsignon A, Pompon J, Giraudeau M, Simard F, Missé D, Lefèvre T, Thomas F. Cancer and mosquitoes - An unsuspected close connection. THE SCIENCE OF THE TOTAL ENVIRONMENT 2020; 743:140631. [PMID: 32758822 DOI: 10.1016/j.scitotenv.2020.140631] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Revised: 06/28/2020] [Accepted: 06/28/2020] [Indexed: 06/11/2023]
Abstract
Cancer is a major public health issue and represents a significant burden in countries with different levels of economic wealth. In parallel, mosquito-borne infectious diseases represent a growing problem causing significant morbidity and mortality worldwide. Acknowledging that these two concerns are both globally distributed, it is essential to investigate whether they have a reciprocal connection that can fuel their respective burdens. Unfortunately, very few studies have examined the link between these two threats. This review provides an overview of the possible links between mosquitoes, mosquito-borne infectious diseases and cancer. We first focus on the impact of mosquitoes on carcinogenesis in humans including the transmission of oncogenic pathogens through mosquitoes, the immune reactions following mosquito bites, the presence of non-oncogenic mosquito-borne pathogens, and the direct transmission of cancer cells. The second part of this review deals with the direct or indirect consequences of cancer in humans on mosquito behaviour. Thirdly, we discuss the potential impacts that natural cancers in mosquitoes can have on their life history traits and therefore on their vector capacity. Finally, we discuss the most promising research avenues on this topic and the integrative public health strategies that could be envisioned in this context.
Collapse
Affiliation(s)
- Audrey Arnal
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
| | - Benjamin Roche
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France; IRD, Sorbonne Université, UMMISCO, F-93143 Bondy, France; Departamento de Etología, Fauna Silvestre y Animales de Laboratorio, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France
| | | | - Antoine Dujon
- Centre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France; School of Life and Environmental Sciences, Centre for Integrative Ecology, Deakin University, Waurn Ponds, VIC, Australia
| | - Beata Ujvari
- School of Life and Environmental Sciences, Centre for Integrative Ecology, Deakin University, Waurn Ponds, VIC, Australia
| | - Vincent Corbel
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France
| | - Franck Remoue
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France
| | | | - Julien Pompon
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France
| | - Mathieu Giraudeau
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France
| | - Frédéric Simard
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France
| | - Dorothée Missé
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France
| | - Thierry Lefèvre
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso
| | - Frédéric Thomas
- MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France; Centre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France
| |
Collapse
|
20
|
Kochevalina MY, Trunov VG, Morozova OV, Kogun GA, Rodionova EI. Change in Urine Odor of Mice in the Dynamics of Formation of a Transplanted Hepatocarcinoma H33 Tumor. BIOL BULL+ 2020. [DOI: 10.1134/s1062359020050052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
21
|
Can mice be trained to discriminate urine odor of conspecifics with melanoma before clinical symptoms appear? J Vet Behav 2020. [DOI: 10.1016/j.jveb.2020.04.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
22
|
Dospinescu VM, Tiele A, Covington JA. Sniffing Out Urinary Tract Infection-Diagnosis Based on Volatile Organic Compounds and Smell Profile. BIOSENSORS 2020; 10:E83. [PMID: 32717983 PMCID: PMC7460005 DOI: 10.3390/bios10080083] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 07/19/2020] [Accepted: 07/20/2020] [Indexed: 02/08/2023]
Abstract
Current available methods for the clinical diagnosis of urinary tract infection (UTI) rely on a urine dipstick test or culturing of pathogens. The dipstick test is rapid (available in 1-2 min), but has a low positive predictive value, while culturing is time-consuming and delays diagnosis (24-72 h between sample collection and pathogen identification). Due to this delay, broad-spectrum antibiotics are often prescribed immediately. The over-prescription of antibiotics should be limited, in order to prevent the development of antimicrobial resistance. As a result, there is a growing need for alternative diagnostic tools. This paper reviews applications of chemical-analysis instruments, such as gas chromatography-mass spectrometry (GC-MS), selected ion flow tube mass spectrometry (SIFT-MS), ion mobility spectrometry (IMS), field asymmetric ion mobility spectrometry (FAIMS) and electronic noses (eNoses) used for the diagnosis of UTI. These methods analyse volatile organic compounds (VOCs) that emanate from the headspace of collected urine samples to identify the bacterial pathogen and even determine the causative agent's resistance to different antibiotics. There is great potential for these technologies to gain wide-spread and routine use in clinical settings, since the analysis can be automated, and test results can be available within minutes after sample collection. This could significantly reduce the necessity to prescribe broad-spectrum antibiotics and allow the faster and more effective use of narrow-spectrum antibiotics.
Collapse
Affiliation(s)
| | - Akira Tiele
- School of Engineering, University of Warwick, Coventry CV4 7AL, UK;
| | | |
Collapse
|
23
|
Tanaka M, Hsuan C, Oeki M, Shen W, Goda A, Tahara Y, Onodera T, Sanematsu K, Rikitake T, Oki E, Ninomiya Y, Kurebayashi R, Sonoda H, Maehara Y, Toko K, Matsui T. Identification of characteristic compounds of moderate volatility in breast cancer cell lines. PLoS One 2020; 15:e0235442. [PMID: 32598404 PMCID: PMC7323966 DOI: 10.1371/journal.pone.0235442] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Accepted: 06/15/2020] [Indexed: 01/26/2023] Open
Abstract
In this study, we were challenging to identify characteristic compounds in breast cancer cell lines. GC analysis of extracts from the culture media of breast cancer cell lines (MCF-7, SK-BR-3, and YMB-1) using a solid-phase Porapak Q extraction revealed that two compounds of moderate volatility, 1-hexadecanol and 5-(Z)-dodecenoic acid, were detected with markedly higher amount than those in the medium of fibroblast cell line (KMST-6). Furthermore, LC-TOF/MS analysis of the extracts clarified that in addition to the above two fatty acids, the amounts of five unsaturated fatty acids [decenoic acid (C10:1), decadienoic acid (C10:2), 5-(Z)-dodecenoic acid (C12:1), 5-(Z)-tetradecenoic acid (C14:1), and tetradecadienoic acid (C14:2)] in MCF-7 medium were higher than those in medium of KMST-6. Interestingly, H2O2-oxidation of 5-(Z)-dodecenoic acid and 5-(Z)-tetradecenoic acid produced volatile aldehydes that were reported as specific volatiles in breath from various cancer patients, such as heptanal, octanal, nonanal, decanal, 2-(E)-nonenal, and 2-(E)-octenal. Thus, we concluded that these identified compounds over-produced in breast cancer cells in this study could serve as potential precursors producing reported cancer-specific volatiles.
Collapse
Affiliation(s)
- Mitsuru Tanaka
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| | - Chung Hsuan
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
| | - Masataka Oeki
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
| | - Weilin Shen
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
| | - Asuka Goda
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
| | - Yusuke Tahara
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| | - Takeshi Onodera
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
- Faculty of Information Science and Electrical Engineering, Kyushu University, Fukuoka, Japan
| | - Keisuke Sanematsu
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
- Section of Oral Neuroscience, Graduate School of Dental Science, Kyushu University, Fukuoka, Japan
| | - Tomotsugu Rikitake
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| | - Eiji Oki
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Yuzo Ninomiya
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| | | | - Hideto Sonoda
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Department of General Surgery, Imari-Arita Kyoritsu Hospital, Saga, Japan
| | - Yoshihiko Maehara
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| | - Kiyoshi Toko
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
- Institute for Advanced Study, Kyushu University, Fukuoka, Japan
| | - Toshiro Matsui
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan
- Research and Development Center for Five-Sense Devices, Kyushu University, Fukuoka, Japan
| |
Collapse
|
24
|
Botticelli A, Vernocchi P, Marini F, Quagliariello A, Cerbelli B, Reddel S, Del Chierico F, Di Pietro F, Giusti R, Tomassini A, Giampaoli O, Miccheli A, Zizzari IG, Nuti M, Putignani L, Marchetti P. Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment. J Transl Med 2020; 18:49. [PMID: 32014010 PMCID: PMC6998840 DOI: 10.1186/s12967-020-02231-0] [Citation(s) in RCA: 102] [Impact Index Per Article: 25.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Accepted: 01/16/2020] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Despite the efficacy of immune checkpoint inhibitors (ICIs) only the 20-30% of treated patients present long term benefits. The metabolic changes occurring in the gut microbiota metabolome are herein proposed as a factor potentially influencing the response to immunotherapy. METHODS The metabolomic profiling of gut microbiota was characterized in 11 patients affected by non-small cell lung cancer (NSCLC) treated with nivolumab in second-line treatment with anti-PD-1 nivolumab. The metabolomics analyses were performed by GC-MS/SPME and 1H-NMR in order to detect volatile and non-volatile metabolites. Metabolomic data were processed by statistical profiling and chemometric analyses. RESULTS Four out of 11 patients (36%) presented early progression, while the remaining 7 out of 11 (64%) presented disease progression after 12 months. 2-Pentanone (ketone) and tridecane (alkane) were significantly associated with early progression, and on the contrary short chain fatty acids (SCFAs) (i.e., propionate, butyrate), lysine and nicotinic acid were significantly associated with long-term beneficial effects. CONCLUSIONS Our preliminary data suggest a significant role of gut microbiota metabolic pathways in affecting response to immunotherapy. The metabolic approach could be a promising strategy to contribute to the personalized management of cancer patients by the identification of microbiota-linked "indicators" of early progressor and long responder patients.
Collapse
Affiliation(s)
- Andrea Botticelli
- Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.,AOU Policlinico Umberto I, Rome, Italy
| | - Pamela Vernocchi
- Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Federico Marini
- Department of Chemistry, Sapienza University of Rome, Rome, Italy.,NMR-based Metabolomics Laboratory, Sapienza University of Rome, Rome, Italy
| | | | - Bruna Cerbelli
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy
| | - Sofia Reddel
- Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | | | | | | | - Alberta Tomassini
- Department of Chemistry, Sapienza University of Rome, Rome, Italy.,NMR-based Metabolomics Laboratory, Sapienza University of Rome, Rome, Italy
| | | | - Alfredo Miccheli
- NMR-based Metabolomics Laboratory, Sapienza University of Rome, Rome, Italy.,Department of Enviromental Biology, University of Rome, Rome, Italy
| | | | - Marianna Nuti
- Department of Experimental Medicine, University Sapienza, Rome, Italy
| | - Lorenza Putignani
- Unit of Parasitology and Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
| | - Paolo Marchetti
- Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.,AOU Policlinico Umberto I, Rome, Italy.,AOU Sant'Andrea Hospital, Rome, Italy
| |
Collapse
|
25
|
Silva CL, Olival A, Perestrelo R, Silva P, Tomás H, Câmara JS. Untargeted Urinary 1H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection. Metabolites 2019; 9:E269. [PMID: 31703396 PMCID: PMC6918409 DOI: 10.3390/metabo9110269] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2019] [Revised: 10/25/2019] [Accepted: 11/06/2019] [Indexed: 12/24/2022] Open
Abstract
Breast cancer (BC) remains the second leading cause of death among women worldwide. An emerging approach based on the identification of endogenous metabolites (EMs) and the establishment of the metabolomic fingerprint of biological fluids constitutes a new frontier in medical diagnostics and a promising strategy to differentiate cancer patients from healthy individuals. In this work we aimed to establish the urinary metabolomic patterns from 40 BC patients and 38 healthy controls (CTL) using proton nuclear magnetic resonance spectroscopy (1H-NMR) as a powerful approach to identify a set of BC-specific metabolites which might be employed in the diagnosis of BC. Orthogonal partial least squares-discriminant analysis (OPLS-DA) was applied to a 1H-NMR processed data matrix. Metabolomic patterns distinguished BC from CTL urine samples, suggesting a unique metabolite profile for each investigated group. A total of 10 metabolites exhibited the highest contribution towards discriminating BC patients from healthy controls (variable importance in projection (VIP) >1, p < 0.05). The discrimination efficiency and accuracy of the urinary EMs were ascertained by receiver operating characteristic curve (ROC) analysis that allowed the identification of some metabolites with the highest sensitivities and specificities to discriminate BC patients from healthy controls (e.g. creatine, glycine, trimethylamine N-oxide, and serine). The metabolomic pathway analysis indicated several metabolism pathway disruptions, including amino acid and carbohydrate metabolisms, in BC patients, namely, glycine and butanoate metabolisms. The obtained results support the high throughput potential of NMR-based urinary metabolomics patterns in discriminating BC patients from CTL. Further investigations could unravel novel mechanistic insights into disease pathophysiology, monitor disease recurrence, and predict patient response towards therapy.
Collapse
Affiliation(s)
- Catarina L. Silva
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
| | - Ana Olival
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
| | - Rosa Perestrelo
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
| | - Pedro Silva
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
| | - Helena Tomás
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
- Faculdade de Ciências Exactas e Engenharia da Universidade da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal
| | - José S. Câmara
- CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal; (C.L.S.); (A.O.); (R.P.); (P.S.); (H.T.)
- Faculdade de Ciências Exactas e Engenharia da Universidade da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal
| |
Collapse
|
26
|
Gao Q, Su X, Annabi MH, Schreiter BR, Prince T, Ackerman A, Morgas S, Mata V, Williams H, Lee WY. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer. Clin Genitourin Cancer 2019; 17:183-190. [PMID: 30853355 DOI: 10.1016/j.clgc.2019.02.003] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2018] [Revised: 02/04/2019] [Accepted: 02/05/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Prostate cancer (PCa) screening using serum prostate-specific antigen (PSA) testing has caused unnecessary biopsies and overdiagnosis owing to its low accuracy and reliability. Therefore, there is an increased interest in identifying better PCa biomarkers. Studies showed that trained dogs can discriminate patients with PCa from unaffected men by sniffing urine. We hypothesized that urinary volatile organic compounds (VOCs) may be the source of that odor and could be used to develop urinary VOC PCa diagnosis models. PATIENTS AND METHODS Urine samples from 55 and 53 biopsy proven PCa-positive and -negative patients respectively were initially obtained for diagnostic model development. Urinary metabolites were analyzed by gas chromatography-mass spectrometry. A PCa diagnosis model was developed and validated using innovative statistical machine-learning techniques. A second set of samples (53 PCa-positive and 22 PCa-negative patients) were used to evaluate the previously developed PCa diagnosis model. RESULTS The analysis resulted in 254 and 282 VOCs for their significant association (P < .05) with either PCa-positive or -negative samples respectively. Regularized logistic regression analysis and the Firth method were then applied to predict PCa prevalence, resulting in a final model that contains 11 VOCs. Under cross-validation, the area under the receiver operating characteristic curve (AUC) for the final model was 0.92 (sensitivity, 0.96; specificity, 0.80). Further evaluation of the developed model using a testing cohort yielded an AUC of 0.86. As a comparison, the PSA-based diagnosis model only rendered an AUC of 0.54. CONCLUSION The study describes the development of a urinary VOC-based model for PCa detection.
Collapse
Affiliation(s)
- Qin Gao
- Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX
| | - Xiaogang Su
- Department of Mathematical Sciences, University of Texas at El Paso, El Paso, TX
| | | | | | | | | | | | | | | | - Wen-Yee Lee
- Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX.
| |
Collapse
|
27
|
Leclercq M, Vittrant B, Martin-Magniette ML, Scott Boyer MP, Perin O, Bergeron A, Fradet Y, Droit A. Large-Scale Automatic Feature Selection for Biomarker Discovery in High-Dimensional OMICs Data. Front Genet 2019; 10:452. [PMID: 31156708 PMCID: PMC6532608 DOI: 10.3389/fgene.2019.00452] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Accepted: 04/30/2019] [Indexed: 12/11/2022] Open
Abstract
The identification of biomarker signatures in omics molecular profiling is usually performed to predict outcomes in a precision medicine context, such as patient disease susceptibility, diagnosis, prognosis, and treatment response. To identify these signatures, we have developed a biomarker discovery tool, called BioDiscML. From a collection of samples and their associated characteristics, i.e., the biomarkers (e.g., gene expression, protein levels, clinico-pathological data), BioDiscML exploits various feature selection procedures to produce signatures associated to machine learning models that will predict efficiently a specified outcome. To this purpose, BioDiscML uses a large variety of machine learning algorithms to select the best combination of biomarkers for predicting categorical or continuous outcomes from highly unbalanced datasets. The software has been implemented to automate all machine learning steps, including data pre-processing, feature selection, model selection, and performance evaluation. BioDiscML is delivered as a stand-alone program and is available for download at https://github.com/mickaelleclercq/BioDiscML.
Collapse
Affiliation(s)
- Mickael Leclercq
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada
| | - Benjamin Vittrant
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada
| | - Marie Laure Martin-Magniette
- Institute of Plant Sciences Paris Saclay IPS2, CNRS, INRA, Université Paris-Sud, Université Evry, Université Paris-Saclay, Paris Diderot, Sorbonne Paris-Cité, Orsay, France.,UMR MIA-Paris, AgroParisTech, INRA, Université Paris-Saclay, Paris, France
| | - Marie Pier Scott Boyer
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada
| | - Olivier Perin
- Digital Sciences Department, L'Oréal Advanced Research, Aulnay-sous-bois, France
| | - Alain Bergeron
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Chirurgie, Oncology Axis, Université Laval, Québec City, QC, Canada
| | - Yves Fradet
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Chirurgie, Oncology Axis, Université Laval, Québec City, QC, Canada
| | - Arnaud Droit
- Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada.,Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada
| |
Collapse
|
28
|
Woollam M, Teli M, Angarita-Rivera P, Liu S, Siegel AP, Yokota H, Agarwal M. Detection of Volatile Organic Compounds (VOCs) in Urine via Gas Chromatography-Mass Spectrometry QTOF to Differentiate Between Localized and Metastatic Models of Breast Cancer. Sci Rep 2019; 9:2526. [PMID: 30792417 PMCID: PMC6384920 DOI: 10.1038/s41598-019-38920-0] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Accepted: 01/09/2019] [Indexed: 01/11/2023] Open
Abstract
Breast cancer is the most common cancer detected in women and current screening methods for the disease are not sensitive. Volatile organic compounds (VOCs) include endogenous metabolites that provide information about health and disease which might be useful to develop a better screening method for breast cancer. The goal of this study was to classify mice with and without tumors and compare tumors localized to the mammary pad and tumor cells injected into the iliac artery by differences in VOCs in urine. After 4T1.2 tumor cells were injected into BALB/c mice either in the mammary pad or into the iliac artery, urine was collected, VOCs from urine headspace were concentrated by solid phase microextraction and results were analyzed by gas chromatography-mass spectrometry quadrupole time-of-flight. Multivariate and univariate statistical analyses were employed to find potential biomarkers for breast cancer and metastatic breast cancer in mice models. A set of six VOCs classified mice with and without tumors with an area under the receiver operator characteristic (ROC AUC) of 0.98 (95% confidence interval [0.85, 1.00]) via five-fold cross validation. Classification of mice with tumors in the mammary pad and iliac artery was executed utilizing a different set of six VOCs, with a ROC AUC of 0.96 (95% confidence interval [0.75, 1.00]).
Collapse
Affiliation(s)
- Mark Woollam
- IUPUI, Department of Chemistry and Chemical Biology, Indianapolis, 46202, USA
- Integrated Nanosystems Development Institute, Indianapolis, 46202, USA
| | - Meghana Teli
- IUPUI, Department of Biomedical Engineering, Indianapolis, 46202, USA
- Integrated Nanosystems Development Institute, Indianapolis, 46202, USA
| | - Paula Angarita-Rivera
- IUPUI, Department of Biomedical Engineering, Indianapolis, 46202, USA
- Integrated Nanosystems Development Institute, Indianapolis, 46202, USA
| | - Shengzhi Liu
- IUPUI, Department of Biomedical Engineering, Indianapolis, 46202, USA
| | - Amanda P Siegel
- IUPUI, Department of Chemistry and Chemical Biology, Indianapolis, 46202, USA
- Integrated Nanosystems Development Institute, Indianapolis, 46202, USA
| | - Hiroki Yokota
- IUPUI, Department of Biomedical Engineering, Indianapolis, 46202, USA
- Biomechanics and Biomaterials Research Center, Indianapolis, 46202, USA
| | - Mangilal Agarwal
- IUPUI, Department of Chemistry and Chemical Biology, Indianapolis, 46202, USA.
- IUPUI, Department of Mechanical Engineering and Energy, Indianapolis, 46202, USA.
- Integrated Nanosystems Development Institute, Indianapolis, 46202, USA.
| |
Collapse
|
29
|
Abstract
The complexity of the human sense of smell is increasingly reflected in complex and high-dimensional data, which opens opportunities for data-driven approaches that complement hypothesis-driven research. Contemporary developments in computational and data science, with its currently most popular implementation as machine learning, facilitate complex data-driven research approaches. The use of machine learning in human olfactory research included major approaches comprising 1) the study of the physiology of pattern-based odor detection and recognition processes, 2) pattern recognition in olfactory phenotypes, 3) the development of complex disease biomarkers including olfactory features, 4) odor prediction from physico-chemical properties of volatile molecules, and 5) knowledge discovery in publicly available big databases. A limited set of unsupervised and supervised machine-learned methods has been used in these projects, however, the increasing use of contemporary methods of computational science is reflected in a growing number of reports employing machine learning for human olfactory research. This review provides key concepts of machine learning and summarizes current applications on human olfactory data.
Collapse
Affiliation(s)
- Jörn Lötsch
- Institute of Clinical Pharmacology, Goethe-University, Frankfurt am Main, Germany
- Fraunhofer Institute of Molecular Biology and Applied Ecology - Project Group Translational Medicine and Pharmacology (IME-TMP), Frankfurt am Main, Germany
| | - Dario Kringel
- Institute of Clinical Pharmacology, Goethe-University, Frankfurt am Main, Germany
| | - Thomas Hummel
- Smell & Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany
| |
Collapse
|
30
|
Identification of volatile metabolites in human saliva from patients with oral squamous cell carcinoma via zeolite-based thin-film microextraction coupled with GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1104:49-58. [PMID: 30445287 DOI: 10.1016/j.jchromb.2018.11.002] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2018] [Revised: 10/04/2018] [Accepted: 11/02/2018] [Indexed: 12/20/2022]
Abstract
In recent years, volatile organic compounds (VOCs) discharged from the human body, of which some compounds exhibit strong correlations with pathological conditions, have attracted attention as a new means of disease diagnosis technology. The aim of this study was to establish the salivary metabolomic profiles of oral squamous cell carcinoma (OSCC) patients and healthy volunteers (control group) and to investigate VOCs as potential biomarkers in the diagnosis of oral cancer. We have demonstrated a method combining thin-film microextraction based on a ZSM-5/polydimethylsiloxane hybrid film coupled with gas chromatography-mass spectrometry and carried out a comparative analysis of salivary VOC profiles between OSCC patients and healthy controls. The results depicted that 42 and 73 VOCs were detected and identified in samples from the healthy control group (n = 50) and oral cancer group (n = 24), respectively. Among them, twenty-seven VOCs (ten were decreased, seven disappeared, and ten were newly produced in the oral cancer group) depict significant differences between both the sample groups, and they have relevance as candidate biomarkers for OSCC. Twelve salivary VOCs that were characteristic of oral cancer patients were finally extracted and used for pattern recognition analyses for oral cancer diagnosis. The proposed TFME approach for analyzing human saliva on the basis of a ZSM-5-loaded PDMS hybrid thin film has been performed for the very first time in the field of dentistry.
Collapse
|
31
|
Gordon AR, Kimball BA, Sorjonen K, Karshikoff B, Axelsson J, Lekander M, Lundström JN, Olsson MJ. Detection of Inflammation via Volatile Cues in Human Urine. Chem Senses 2018; 43:711-719. [DOI: 10.1093/chemse/bjy059] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Affiliation(s)
- Amy R Gordon
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Monell Chemical Senses Center, Philadelphia, PA, USA
| | - Bruce A Kimball
- Monell Chemical Senses Center, Philadelphia, PA, USA
- USDA-APHIS-WS, National Wildlife Research Center, Monell Chemical Senses Center, Philadelphia, PA, USA
| | - Kimmo Sorjonen
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Bianka Karshikoff
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Stress Research Institute, Stockholm University, Stockholm, Sweden
- Osher Center for Integrative Medicine, Karolinska Institute, Stockholm, Sweden
- Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto, CA, USA
| | - John Axelsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Stress Research Institute, Stockholm University, Stockholm, Sweden
- Osher Center for Integrative Medicine, Karolinska Institute, Stockholm, Sweden
| | - Mats Lekander
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Stress Research Institute, Stockholm University, Stockholm, Sweden
- Osher Center for Integrative Medicine, Karolinska Institute, Stockholm, Sweden
| | - Johan N Lundström
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Monell Chemical Senses Center, Philadelphia, PA, USA
- Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA
| | - Mats J Olsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
32
|
Porto-Figueira P, Pereira J, Miekisch W, Câmara JS. Exploring the potential of NTME/GC-MS, in the establishment of urinary volatomic profiles. Lung cancer patients as case study. Sci Rep 2018; 8:13113. [PMID: 30166567 PMCID: PMC6117359 DOI: 10.1038/s41598-018-31380-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 08/16/2018] [Indexed: 12/20/2022] Open
Abstract
The growing cancer incidence and mortality worldwide claims for the development of novel diagnostic strategies. In this study we aimed to explore the potential of an innovative methodology, based on a needle trap microextraction (NTME), combined with gas chromatography-mass spectrometry (GC-MS), as new approach to isolate and profile urinary volatile organic metabolites (VOMs) from lung cancer (LC) patients and healthy individuals (CTRL). In this context, different experimental parameters with influence of NTME extraction efficiency including, temperature, equilibration time, headspace volume, ionic strength, pH, effects of sample volume and stirring, were investigated and optimized. For the DVB/CarX/Car1000 needle trap device (NTD), the best results were obtained using 40 mL headspace of a 4-mL acidified (pH = 2) urine sample with 20% NaCl and an extraction temperature of 50 °C for 40 min of equilibration time. The stability of the isolated VOMs was investigated up to 72 h after extraction. From the VOMs identified, belonging namely to ketones, sulphur and benzene derivatives, 98 presented a frequency of occurrence above 90%. Data were processed by discriminant analysis, retrieving differentiated clusters for LC and CTRL groups. As far we are aware, this is the first study using NTME/GC-MS to establish urinary volatomic profiles. Preliminary results are very promising, as broad and comprehensive volatile profiles were obtained. Moreover, the extended storage stability of the NTD devices opens new opportunities for sampling other matrices in a wide range of applications.
Collapse
Affiliation(s)
- Priscilla Porto-Figueira
- CQM - Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105, Funchal, Portugal
| | - Jorge Pereira
- CQM - Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105, Funchal, Portugal
| | - Wolfram Miekisch
- Department of Anaesthesiology and Intensive Care Medicine, Rostock Medical Breath Research Analytics and Technologies (ROMBAT), University Medicine Rostock, Rostock, Germany
| | - José S Câmara
- CQM - Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105, Funchal, Portugal.
- Faculdade de Ciências Exatas e da Engenharia da Universidade da Madeira, Campus Universitário da Penteada, 9020-105, Funchal, Portugal.
| |
Collapse
|
33
|
Jalal AH, Alam F, Roychoudhury S, Umasankar Y, Pala N, Bhansali S. Prospects and Challenges of Volatile Organic Compound Sensors in Human Healthcare. ACS Sens 2018; 3:1246-1263. [PMID: 29879839 DOI: 10.1021/acssensors.8b00400] [Citation(s) in RCA: 100] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The chemical signatures of volatile organic compounds (VOCs) in humans can be utilized for point-of-care (POC) diagnosis. Apart from toxic exposure studies, VOCs generated in humans can provide insights into one's healthy and diseased metabolic states, acting as a biomarker for identifying numerous diseases noninvasively. VOC sensors and the technology of e-nose have received significant attention for continuous and selective monitoring of various physiological and pathophysiological conditions of an individual. Noninvasive detection of VOCs is achieved from biomatrices of breath, sweat and saliva. Among these, detection from sweat and saliva can be continuous in real-time. The sensing approaches include optical, chemiresistive and electrochemical techniques. This article provides an overview of such techniques. These, however, have limitations of reliability, precision, selectivity, and stability in continuous monitoring. Such limitations are due to lack of sensor stability and complexity of samples in a multivariate environment, which can lead to false readings. To overcome selectivity barriers, sensor arrays enabling multimodal sensing, have been used with pattern recognition techniques. Stability and precision issues have been addressed through advancements in nanotechnology. The use of various forms of nanomaterial not only enhance sensing performance, but also plays a major role in detection on a miniaturized scale. The rapid growth in medical Internet of Things (IoT) and artificial intelligence paves a pathway for improvements in human theranostics.
Collapse
Affiliation(s)
- Ahmed H. Jalal
- Department of Electrical and Computer Engineering, Florida International University, Miami, Florida 33174, United States
| | - Fahmida Alam
- Department of Electrical and Computer Engineering, Florida International University, Miami, Florida 33174, United States
| | - Sohini Roychoudhury
- Department of Electrical and Computer Engineering, Florida International University, Miami, Florida 33174, United States
| | - Yogeswaran Umasankar
- Biomolecular Sciences Institute, Florida International University, Miami, Florida 33199, United States
| | - Nezih Pala
- Department of Electrical and Computer Engineering, Florida International University, Miami, Florida 33174, United States
| | - Shekhar Bhansali
- Department of Electrical and Computer Engineering, Florida International University, Miami, Florida 33174, United States
| |
Collapse
|
34
|
Shahid M, Lee MY, Yeon A, Cho E, Sairam V, Valdiviez L, You S, Kim J. Menthol, a unique urinary volatile compound, is associated with chronic inflammation in interstitial cystitis. Sci Rep 2018; 8:10859. [PMID: 30022124 PMCID: PMC6052149 DOI: 10.1038/s41598-018-29085-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Accepted: 06/25/2018] [Indexed: 12/04/2022] Open
Abstract
Chronic inflammation is a potential systemic risk factor for many bladder dysfunctions, including interstitial cystitis (IC). However, the underlying mechanism through which a healthy bladder protects itself from inflammatory triggers remains unknown. In this study, we identified odor compounds in urine obtained from IC patients and healthy controls. Using comprehensive solid-phase microextraction-gas chromatography-time-of-flight-mass spectrometry (SPME-GC-TOF-MS) profiling and bioinformatics, we found that levels of urinary volatile metabolites, such as menthol, were significantly reduced in IC patients, compared to healthy controls. In an attempt to understand the mechanistic meaning of our volatile metabolites data and the role of menthol in the immune system, we performed two independent experiments: (a) cytokine profiling, and (b) DNA microarray. Our findings suggest that lipopolysaccharide (LPS)-stimulated inflammatory events, such as the production and secretion of inflammatory cytokines (e.g., TNF-α, IL-6, and IL-1β) and the activation of NF-κB and associated proteins within a large signaling network (e.g., Akt, TLR1, TNFAIP3, and NF-κB), are suppressed by the presence of menthol. These findings broaden our knowledge on the role of urinary menthol in suppressing inflammatory events and provide potential new strategies for alleviating both the odor and inflammation associated with IC.
Collapse
Affiliation(s)
- Muhammad Shahid
- Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | | | - Austin Yeon
- Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Eunho Cho
- University of California Los Angeles, Los Angeles, CA, USA
| | - Vikram Sairam
- University of California Los Angeles, Los Angeles, CA, USA
| | - Luis Valdiviez
- West Coast Metabolomics Center, UC Davis, Davis, CA, 95616, USA
| | - Sungyong You
- Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Jayoung Kim
- Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- University of California Los Angeles, Los Angeles, CA, USA.
- Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Urology, Ga Cheon University College of Medicine, Incheon, South Korea.
| |
Collapse
|
35
|
Opitz P, Herbarth O. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC). J Otolaryngol Head Neck Surg 2018; 47:42. [PMID: 29970175 PMCID: PMC6029417 DOI: 10.1186/s40463-018-0288-5] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2017] [Accepted: 06/25/2018] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Different organisms such as bacteria, molds and humans produce and release a relative unknown class of metabolites which are responsible for the individual olfactory pattern. These volatile organic metabolites (VOM) represent a kind of biosignature that reflects the sum of all multifactorial influences, including genetics, environmental factors, nutritional and disease status. As a result of pathological processes the individual body odor can be influenced by newly produced or altered compositions of the VOM. Until now, human VOM have been detected in various body media, such as on the skin, in the exhaled air as well as in body fluids such as saliva, mother's milk, sweat, blood and urine. METHODS In this retrospective case-control study urinary VOM of 53 therapy-naive patients with head and neck squamous cell carcinoma (HNSCC) and 82 healthy controls were semi-quantified by headspace solid-phase micro extraction (SPME) gas chromatography (GC) mass spectrometry (MS). At first, the procedure was optimized in respect to the extraction parameters. By using Student's t-test significant differences in the VOM pattern with the corresponding p-values were obtained. For multivariate metabolite pattern recognition the hierarchical cluster analysis by Ward was applied, followed by the supervised partial least squares-discriminant analysis (PLS-DA). RESULTS In total 81 VOMs could identified in the urine samples of all study participants, of which 25 were significantly increased and of which were 10 significantly reduced in HNSCC-patients compared to the controls. In addition, the multivariate statistics confirmed that on the basis of the renal excreted pattern of the volatile metabolites a high discrimination can be carried out between patients with a tumor in the head and neck region and controls. The substance group of the saturated, unbranched aldehydes makes a substantial contribution in this context. CONCLUSIONS The systematic pattern analysis of urinary VOMs appears to have potential clinical application as a diagnostic tool for cancer, especially HNSCC.
Collapse
Affiliation(s)
- Philipp Opitz
- Institute of Hygiene, Hospital Hygiene and Environmental Medicine, University Hospital Leipzig, Johannisallee 34, 04103, Leipzig, Germany.
| | - Olf Herbarth
- Institute of Environmental Medicine and Hygiene, Faculty of Medicine, University of Leipzig, Liebigstr. 27, 04103, Leipzig, Germany
| |
Collapse
|
36
|
Fischer-Tenhagen C, Johnen D, Nehls I, Becker R. A Proof of Concept: Are Detection Dogs a Useful Tool to Verify Potential Biomarkers for Lung Cancer? Front Vet Sci 2018; 5:52. [PMID: 29594162 PMCID: PMC5861141 DOI: 10.3389/fvets.2018.00052] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Accepted: 03/01/2018] [Indexed: 01/26/2023] Open
Abstract
Early and reliable diagnostic test is essential for effective therapy of lung cancer. Volatile organic compounds that are characteristic for cancer could serve as valuable biomarkers in cancer diagnosis. Both trace analytical and detection dog approaches give some evidence for the existence of such biomarkers. In this proof of concept, study dogs and trace analysis were implemented in combination to gain more information concerning cancer biomarkers. Two dogs were trained to distinguish between absorbed breath samples of lung cancer patients and healthy persons and succeeded with correct identification of patients with 9/9 and 8/9 and correct negative indications from of 8/10 and 4/10 samples from healthy individuals. A recent observational study found that breath samples from lung cancer patients showed an increase in 1-butanol, 2-butanone, 2-pentanone, and hexanal. Synthetic air samples were therefore fortified with these compounds and adsorbed to a fleece. Tested against breath samples from healthy probands, on presentation to the dogs these synthetic samples provoked an indication in three out of four samples. We were able to demonstrate that a combination of the natural nose of a dog and a trace analytic technique can be a valuable concept in the search for cancer biomarkers.
Collapse
Affiliation(s)
| | - Dorothea Johnen
- Clinic of Animal Reproduction, Freie Universität Berlin, Berlin, Germany
| | - Irene Nehls
- Bundesanstalt für Materialforschung und -prüfung (BAM), Berlin, Germany
| | - Roland Becker
- Bundesanstalt für Materialforschung und -prüfung (BAM), Berlin, Germany
| |
Collapse
|
37
|
Gas chromatographic-mass spectrometric analysis of urinary volatile organic metabolites: Optimization of the HS-SPME procedure and sample storage conditions. Talanta 2018; 176:537-543. [DOI: 10.1016/j.talanta.2017.08.064] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Revised: 08/16/2017] [Accepted: 08/20/2017] [Indexed: 12/27/2022]
|
38
|
Popov N, Honaker LW, Popova M, Usol'tseva N, Mann EK, Jákli A, Popov P. Thermotropic Liquid Crystal-Assisted Chemical and Biological Sensors. MATERIALS (BASEL, SWITZERLAND) 2017; 11:E20. [PMID: 29295530 PMCID: PMC5793518 DOI: 10.3390/ma11010020] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/27/2017] [Revised: 12/20/2017] [Accepted: 12/20/2017] [Indexed: 01/30/2023]
Abstract
In this review article, we analyze recent progress in the application of liquid crystal-assisted advanced functional materials for sensing biological and chemical analytes. Multiple research groups demonstrate substantial interest in liquid crystal (LC) sensing platforms, generating an increasing number of scientific articles. We review trends in implementing LC sensing techniques and identify common problems related to the stability and reliability of the sensing materials as well as to experimental set-ups. Finally, we suggest possible means of bridging scientific findings to viable and attractive LC sensor platforms.
Collapse
Affiliation(s)
- Nicolai Popov
- Department of Biology & Chemistry, Ivanovo State University, 153025 Ivanovo, Russia.
- Nanomaterials Research Institute, Ivanovo State University, 153025 Ivanovo, Russia.
| | - Lawrence W Honaker
- Physics and Materials Science Research Unit, University of Luxembourg, L-1511 Luxembourg, Luxembourg.
| | - Maia Popova
- Department of Chemistry & Biochemistry, Miami University, Oxford, OH 45056, USA.
| | - Nadezhda Usol'tseva
- Nanomaterials Research Institute, Ivanovo State University, 153025 Ivanovo, Russia.
| | | | - Antal Jákli
- Liquid Crystal Institute, Kent State University, Kent, OH 44242, USA.
| | | |
Collapse
|
39
|
Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours. Sci Rep 2017; 7:14628. [PMID: 29116175 PMCID: PMC5676727 DOI: 10.1038/s41598-017-15355-z] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2017] [Accepted: 10/24/2017] [Indexed: 01/11/2023] Open
Abstract
Similar to fingerprints, humans have unique, genetically determined body odours. In case of urine, the odour can change due to variations in diet as well as upon infection or tumour formation. We investigated the use of mice in a manner similar to “sniffer dogs” to detect changes in urine odour in patients with bladder cancer. We measured the odour discrimination thresholds of mice in a Y-maze, using urine mixtures from patients with bladder cancer (Stage I) and healthy volunteers (dietary variations) as well as occult blood- or antibiotic drug metabolite-modulated samples. Threshold difference indicated that intensities of urinary olfactory cues increase in the following order: dietary variation < bladder cancer < occult blood < antibiotic drug metabolites. After training with patient urine mixtures, sniffer mice discriminated between urine odours of pre- and post-transurethral resection in individual patients with bladder cancer in an equal-occult blood diluted condition below the detection level of dietary variations, achieving a success rate of 100% (11/11). Furthermore, genetic ablation of all dorsal olfactory receptors elevated the discrimination thresholds of mice by ≥ 105-fold. The marked reduction in discrimination sensitivity indicates an essential role of the dorsal olfactory receptors in the recognition of urinary body odours in mice.
Collapse
|
40
|
Monteiro M, Moreira N, Pinto J, Pires-Luís AS, Henrique R, Jerónimo C, Bastos MDL, Gil AM, Carvalho M, Guedes de Pinho P. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. J Cell Mol Med 2017; 21:2092-2105. [PMID: 28378454 PMCID: PMC5571542 DOI: 10.1111/jcmm.13132] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Accepted: 01/20/2017] [Indexed: 12/20/2022] Open
Abstract
The analysis of volatile organic compounds (VOCs) emanating from biological samples appears as one of the most promising approaches in metabolomics for the study of diseases, namely cancer. In fact, it offers advantages, such as non‐invasiveness and robustness for high‐throughput applications. The purpose of this work was to study the urinary volatile metabolic profile of patients with renal cell carcinoma (RCC) (n = 30) and controls (n = 37) with the aim of identifying a potential specific urinary volatile pattern as a non‐invasive strategy to detect RCC. Moreover, the effect of some confounding factors such as age, gender, smoking habits and body mass index was evaluated as well as the ability of urinary VOCs to discriminate RCC subtypes and stages. A headspace solid‐phase microextraction/gas chromatography–mass spectrometry‐based method was performed, followed by multivariate data analysis. A variable selection method was applied to reduce the impact of potential redundant and noisy chromatographic variables, and all models were validated by Monte Carlo cross‐validation and permutation tests. Regarding the effect of RCC on the urine VOCs composition, a panel of 21 VOCs descriptive of RCC was defined, capable of discriminating RCC patients from controls in principal component analysis. Discriminant VOCs were further individually validated in two independent samples sets (nine RCC patients and 12 controls, seven RCC patients with diabetes mellitus type 2) by univariate statistical analysis. Two VOCs were found consistently and significantly altered between RCC and controls (2‐oxopropanal and, according to identification using NIST14, 2,5,8‐trimethyl‐1,2,3,4‐tetrahydronaphthalene‐1‐ol), strongly suggesting enhanced potential as RCC biomarkers. Gender, smoking habits and body mass index showed negligible and age‐only minimal effects on the urinary VOCs, compared to the deviations resultant from the disease. Moreover, in this cohort, the urinary volatilome did not show ability to discriminate RCC stages and histological subtypes. The results validated the value of urinary volatilome for the detection of RCC and advanced with the identification of potential RCC urinary biomarkers.
Collapse
Affiliation(s)
- Márcia Monteiro
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Nathalie Moreira
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Joana Pinto
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Ana S Pires-Luís
- Cancer Biology & Epigenetics Group, Portuguese Oncology Institute of Porto (IPOPorto), Porto, Portugal.,Department of Pathology, Portuguese Oncology Institute of Porto (IPOPorto), Porto, Portugal
| | - Rui Henrique
- Cancer Biology & Epigenetics Group, Portuguese Oncology Institute of Porto (IPOPorto), Porto, Portugal.,Department of Pathology, Portuguese Oncology Institute of Porto (IPOPorto), Porto, Portugal.,Department of Pathology and Molecular Immunology-Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
| | - Carmen Jerónimo
- Cancer Biology & Epigenetics Group, Portuguese Oncology Institute of Porto (IPOPorto), Porto, Portugal.,Department of Pathology and Molecular Immunology-Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
| | - Maria de Lourdes Bastos
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Ana M Gil
- CICECO-Instituto de Materiais de Aveiro (CICECO/UA), Departamento de Química, Universidade de Aveiro, Aveiro, Portugal
| | - Márcia Carvalho
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal.,UFP Energy, Environment and Health Research Unit (FP-ENAS), Universidade Fernando Pessoa, Porto, Portugal
| | - Paula Guedes de Pinho
- UCIBIO@REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| |
Collapse
|
41
|
Machado TR, Alves GJ, Quinteiro-Filho WM, Palermo-Neto J. Cohabitation with an Ehrlich tumor-bearing cagemate induces immune but not behavioral changes in male mice. Physiol Behav 2017; 169:82-89. [DOI: 10.1016/j.physbeh.2016.11.022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2016] [Revised: 10/05/2016] [Accepted: 11/19/2016] [Indexed: 01/11/2023]
|
42
|
Peng B, Ganapathy S, Shen L, Huang J, Yi B, Zhou X, Dai W, Chen C. Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras. Oncotarget 2016; 6:22328-37. [PMID: 26041886 PMCID: PMC4673166 DOI: 10.18632/oncotarget.4084] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Accepted: 05/13/2015] [Indexed: 11/29/2022] Open
Abstract
The pro-survival factor Bcl-2 and its family members are critical determinants of the threshold of the susceptibility of cells to apoptosis. Studies are shown that cells harboring an oncogenic ras were extremely sensitive to the inhibition of protein kinase C (PKC) and Bcl-2 could antagonize this apoptotic process. However, it remains unrevealed how Bcl-2 is being regulated in this apoptotic process. In this study, we investigate the role of Bcl-2 stability in sensitizing the cells harboring oncogenic K-ras to apoptosis triggered by PKC inhibitor GO6976. We demonstrated that Bcl-2 in Swiss3T3 cells ectopically expressing or murine lung cancer LKR cells harboring K-ras rapidly underwent ubiquitin-dependent proteasome pathway after the treatment of GO6976, accompanied with induction of apoptosis. In this process, Bcl-2 formed the complex with Keap-1 and Cul3. The mutation of serine-17 and deletion of BH-2 or 4 was required for Bcl-2 ubiquitination and degradation, which elevate the signal threshold for the induction of apoptosis in the cells following PKC inhibition. Thus, Bcl-2 appears an attractive target for the induction of apoptosis by PKC inhibition in cancer cells expressing oncogenic K-ras.
Collapse
Affiliation(s)
- Bo Peng
- Center for Drug Discovery, Northeastern University, Boston, MA, USA
| | | | - Ling Shen
- Center for Drug Discovery, Northeastern University, Boston, MA, USA
| | - Junchi Huang
- Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden
| | - Bo Yi
- Center for Drug Discovery, Northeastern University, Boston, MA, USA.,The Jiangxi Province Tumor Hospital, Nanchang, China
| | - Xiaodong Zhou
- Center for Drug Discovery, Northeastern University, Boston, MA, USA.,The First Affiliated Hospital of Nanchang University, Nanchang University School of Medicine, Nanchang, China
| | - Wei Dai
- Department of Environmental Medicine, New York University, Tuxedo, NY, USA
| | - Changyan Chen
- Center for Drug Discovery, Northeastern University, Boston, MA, USA.,Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.,The First Affiliated Hospital of Nanchang University, Nanchang University School of Medicine, Nanchang, China
| |
Collapse
|
43
|
Huang Z, Zhang J, Zhang P, Wang H, Pan Z, Wang L. Analysis of volatile organic compounds in pleural effusions by headspace solid-phase microextraction coupled with cryotrap gas chromatography and mass spectrometry. J Sep Sci 2016; 39:2544-52. [DOI: 10.1002/jssc.201600279] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2016] [Revised: 04/24/2016] [Accepted: 04/26/2016] [Indexed: 12/19/2022]
Affiliation(s)
- Zhongping Huang
- College of Chemical Engineering; Zhejiang University of Technology; Hangzhou China
| | - Jie Zhang
- College of Chemical Engineering; Zhejiang University of Technology; Hangzhou China
| | - Peipei Zhang
- College of Chemical Engineering; Zhejiang University of Technology; Hangzhou China
| | - Hong Wang
- Respiratory Department; Zhejiang Provincial People's Hospital; Hangzhou China
| | - Zaifa Pan
- College of Chemical Engineering; Zhejiang University of Technology; Hangzhou China
| | - Lili Wang
- College of Chemical Engineering; Zhejiang University of Technology; Hangzhou China
| |
Collapse
|
44
|
Kimball BA, Cohen AS, Gordon AR, Opiekun M, Martin T, Elkind J, Lundström JN, Beauchamp GK. Brain Injury Alters Volatile Metabolome. Chem Senses 2016; 41:407-14. [PMID: 26926034 DOI: 10.1093/chemse/bjw014] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Chemical signals arising from body secretions and excretions communicate information about health status as have been reported in a range of animal models of disease. A potential common pathway for diseases to alter chemical signals is via activation of immune function-which is known to be intimately involved in modulation of chemical signals in several species. Based on our prior findings that both immunization and inflammation alter volatile body odors, we hypothesized that injury accompanied by inflammation might correspondingly modify the volatile metabolome to create a signature endophenotype. In particular, we investigated alteration of the volatile metabolome as a result of traumatic brain injury. Here, we demonstrate that mice could be trained in a behavioral assay to discriminate mouse models subjected to lateral fluid percussion injury from appropriate surgical sham controls on the basis of volatile urinary metabolites. Chemical analyses of the urine samples similarly demonstrated that brain injury altered urine volatile profiles. Behavioral and chemical analyses further indicated that alteration of the volatile metabolome induced by brain injury and alteration resulting from lipopolysaccharide-associated inflammation were not synonymous. Monitoring of alterations in the volatile metabolome may be a useful tool for rapid brain trauma diagnosis and for monitoring recovery.
Collapse
Affiliation(s)
- Bruce A Kimball
- USDA-APHIS-WS-NWRC, Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA,
| | - Akiva S Cohen
- Children's Hospital of Philadelphia Research Institute, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA
| | - Amy R Gordon
- Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA and Department of Clinical Neuroscience, Karolinska Institutet, Nobels vag 9, 17177 Stockholm, Sweden
| | - Maryanne Opiekun
- Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA and
| | - Talia Martin
- Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA and
| | - Jaclynn Elkind
- Children's Hospital of Philadelphia Research Institute, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA
| | - Johan N Lundström
- Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA and Department of Clinical Neuroscience, Karolinska Institutet, Nobels vag 9, 17177 Stockholm, Sweden
| | - Gary K Beauchamp
- Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA and
| |
Collapse
|
45
|
Kwak J, Jackson M, Faranda A, Osada K, Tashiro T, Mori K, Quan Y, Voznessenskaya VV, Preti G. On the persistence of mouse urine odour to human observers: a review. FLAVOUR FRAG J 2016. [DOI: 10.1002/ffj.3316] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Jae Kwak
- Research Institute of Wildlife Ecology, Department of Integrative Biology and Evolution; University of Veterinary Medicine Vienna; Austria
- Monell Chemical Senses Center; 3500 Market Street Philadelphia PA 19104 USA
| | - Marcus Jackson
- Monell Chemical Senses Center; 3500 Market Street Philadelphia PA 19104 USA
| | - Adam Faranda
- Monell Chemical Senses Center; 3500 Market Street Philadelphia PA 19104 USA
| | - Kazumi Osada
- Department of Oral Biology, Division of Physiology, School of Dentistry; Health Sciences University of Hokkaido; Ishikari-Tobetsu Hokkaido 061-0293 Japan
| | - Takuya Tashiro
- Program for Drug Discovery and Medical Technology Platforms; RIKEN Research Cluster for Innovation; Hirosawa 2-1, Wako Saitama 351-0198 Japan
| | - Kenji Mori
- Program for Drug Discovery and Medical Technology Platforms; RIKEN Research Cluster for Innovation; Hirosawa 2-1, Wako Saitama 351-0198 Japan
| | - Ying Quan
- Suzhou Key Lab of Food Quality and Safety; Changshu Institute of Technology; 99 Nansanhuan Road Changshu 215500 Jiangsu Province P. R. China
| | - Vera V. Voznessenskaya
- A.N. Severtzov Institute of Ecology and Evolution RAS; 33 Leninski Prospect Moscow 119071 Russia
| | - George Preti
- Monell Chemical Senses Center; 3500 Market Street Philadelphia PA 19104 USA
- Department of Dermatology, School of Medicine; University of Pennsylvania; Philadelphia PA 19104 USA
| |
Collapse
|
46
|
Kimball BA, Wilson DA, Wesson DW. Alterations of the volatile metabolome in mouse models of Alzheimer's disease. Sci Rep 2016; 6:19495. [PMID: 26762470 PMCID: PMC4725859 DOI: 10.1038/srep19495] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2015] [Accepted: 12/14/2015] [Indexed: 12/17/2022] Open
Abstract
In the present study, we tested whether the volatile metabolome was altered by mutations of the Alzheimer's disease (AD)-implicated amyloid precursor protein gene (APP) and comprehensively examined urinary volatiles that may potentially serve as candidate biomarkers of AD. Establishing additional biomarkers in screening populations for AD will provide enhanced diagnostic specificity and will be critical in evaluating disease-modifying therapies. Having strong evidence of gross changes in the volatile metabolome of one line of APP mice, we utilized three unique mouse lines which over-express human mutations of the APP gene and their respective non-transgenic litter-mates (NTg). Head-space gas chromatography/mass spectrometry (GC/MS) of urinary volatiles uncovered several aberrant chromatographic peak responses. We later employed linear discrimination analysis and found that the GC/MS peak responses provide accurate (>84%) genotype classification of urinary samples. These initial data in animal models show that mutant APP gene expression entails a uniquely identifiable urinary odor, which if uncovered in clinical AD populations, may serve as an additional biomarker for the disease.
Collapse
Affiliation(s)
- Bruce A. Kimball
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, Monell Chemical Senses Center, Philadelphia, PA 19104
| | - Donald A. Wilson
- Emotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, 10962
- Department of Child & Adolescent Psychiatry, New York University School of Medicine, New York, NY, 10016
| | - Daniel W. Wesson
- Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106
- Department of Biology, Case Western Reserve University, Cleveland, OH 44106
| |
Collapse
|
47
|
Mazzone PJ, Wang XF, Lim S, Choi H, Jett J, Vachani A, Zhang Q, Beukemann M, Seeley M, Martino R, Rhodes P. Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer. BMC Cancer 2015; 15:1001. [PMID: 26698840 PMCID: PMC4690321 DOI: 10.1186/s12885-015-1996-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2015] [Accepted: 12/11/2015] [Indexed: 12/26/2022] Open
Abstract
Background The mixture of volatile organic compounds in the headspace gas of urine may be able to distinguish lung cancer patients from relevant control populations. Methods Subjects with biopsy confirmed untreated lung cancer, and others at risk for developing lung cancer, provided a urine sample. A colorimetric sensor array was exposed to the headspace gas of neat and pre-treated urine samples. Random forest models were trained from the sensor output of 70 % of the study subjects and were tested against the remaining 30 %. Models were developed to separate cancer and cancer subgroups from control, and to characterize the cancer. An additional model was developed on the largest clinical subgroup. Results 90 subjects with lung cancer and 55 control subjects participated. The accuracies, reported as C-statistics, for models of cancer or cancer subgroups vs. control ranged from 0.795 – 0.917. A model of lung cancer vs. control built using only subjects from the largest available clinical subgroup (30 subjects) had a C-statistic of 0.970. Models developed and tested to characterize cancer histology, and to compare early to late stage cancer, had C-statistics of 0.849 and 0.922 respectively. Conclusions The colorimetric sensor array signature of volatile organic compounds in the urine headspace may be capable of distinguishing lung cancer patients from clinically relevant controls. The incorporation of clinical phenotypes into the development of this biomarker may optimize its accuracy.
Collapse
Affiliation(s)
- Peter J Mazzone
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | - Xiao-Feng Wang
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | - Sung Lim
- Metabolomx, Mountainview, CA, USA.
| | - Humberto Choi
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | - James Jett
- National Jewish Health, Denver, CO, USA.
| | - Anil Vachani
- University of Pennsylvania, Philadelphia, PA, USA.
| | - Qi Zhang
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | - Mary Beukemann
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | - Meredith Seeley
- Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave., A90, Cleveland, OH, 44195, USA.
| | | | | |
Collapse
|
48
|
Larisika M, Kotlowski C, Steininger C, Mastrogiacomo R, Pelosi P, Schütz S, Peteu SF, Kleber C, Reiner-Rozman C, Nowak C, Knoll W. Electronic Olfactory Sensor Based on A. mellifera Odorant-Binding Protein 14 on a Reduced Graphene Oxide Field-Effect Transistor. Angew Chem Int Ed Engl 2015; 54:13245-8. [PMID: 26364873 PMCID: PMC4768645 DOI: 10.1002/anie.201505712] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2015] [Indexed: 11/11/2022]
Abstract
An olfactory biosensor based on a reduced graphene oxide (rGO) field-effect transistor (FET), functionalized by the odorant-binding protein 14 (OBP14) from the honey bee (Apis mellifera) has been designed for the in situ and real-time monitoring of a broad spectrum of odorants in aqueous solutions known to be attractants for bees. The electrical measurements of the binding of all tested odorants are shown to follow the Langmuir model for ligand-receptor interactions. The results demonstrate that OBP14 is able to bind odorants even after immobilization on rGO and can discriminate between ligands binding within a range of dissociation constants from K(d)=4 μM to K(d)=3.3 mM. The strongest ligands, such as homovanillic acid, eugenol, and methyl vanillate all contain a hydroxy group which is apparently important for the strong interaction with the protein.
Collapse
Affiliation(s)
- Melanie Larisika
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore)
| | - Caroline Kotlowski
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | | | - Rosa Mastrogiacomo
- Department of Biology of Agriculture, Food and Environment, University of Pisa (Italy)
| | - Paolo Pelosi
- Department of Biology of Agriculture, Food and Environment, University of Pisa (Italy)
| | - Stefan Schütz
- Buesgen-Institute, Dept. of Forest Zoology and Forest Conservation, Goettingen (Germany)
| | - Serban F Peteu
- Michigan State University, Chemical Engineering & Materials Science (USA)
| | - Christoph Kleber
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Ciril Reiner-Rozman
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Christoph Nowak
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Wolfgang Knoll
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria).
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore).
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria).
| |
Collapse
|
49
|
Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls. Sci Rep 2015; 5:14744. [PMID: 26443483 PMCID: PMC4595831 DOI: 10.1038/srep14744] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Accepted: 09/07/2015] [Indexed: 02/04/2023] Open
Abstract
Urinary volatile organic compounds (VOCs) analysis for kidney diseases has attracted a large amount of scientific interest recently, and urinary metabolite analysis has already been applied to many diseases. Urine was collected from 15 mesangial proliferative glomerulonephritis (MsPGN) patients, 21 IgA nephropathy (IgAN) patients and 15 healthy controls. Solid phase microextraction-chromatography- mass spectrometry (SPME-GC-MS) was used to analyse the urinary metabolites. The statistical methods principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLSDA) were performed to process the final data. Five metabolites were significantly greater in the group of MsPGN patients than in the normal control group (P < 0.05) while three metabolites were found at increased levels in the group of IgAN patients compared with the normal controls (P < 0.05). In addition, five metabolites were significantly increased in the group of IgAN patients compared with the MsPGN patients (P < 0.05). These five metabolites may be specific biomarkers for distinguishing between MsPGN and IgAN. The analysis of urinary VOCs appears to have potential clinical applications as a diagnostic tool.
Collapse
|
50
|
Larisika M, Kotlowski C, Steininger C, Mastrogiacomo R, Pelosi P, Schütz S, Peteu SF, Kleber C, Reiner‐Rozman C, Nowak C, Knoll W. Electronic Olfactory Sensor Based on
A. mellifera
Odorant‐Binding Protein 14 on a Reduced Graphene Oxide Field‐Effect Transistor. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201505712] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Melanie Larisika
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore)
| | - Caroline Kotlowski
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | | | - Rosa Mastrogiacomo
- Department of Biology of Agriculture, Food and Environment, University of Pisa (Italy)
| | - Paolo Pelosi
- Department of Biology of Agriculture, Food and Environment, University of Pisa (Italy)
| | - Stefan Schütz
- Buesgen‐Institute, Dept. of Forest Zoology and Forest Conservation, Goettingen (Germany)
| | - Serban F. Peteu
- Michigan State University, Chemical Engineering & Materials Science (USA)
| | - Christoph Kleber
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Ciril Reiner‐Rozman
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Christoph Nowak
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| | - Wolfgang Knoll
- BioSensor Technologies, Austrian Institute of Technology, Vienna (Austria)
- Centre for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637371 (Singapore)
- Center for Electrochemical Surface Technology, Wiener Neustadt (Austria)
| |
Collapse
|